文献速递慢性肾脏病遗传性与小管间质肾病

纤毛ARL13B通过其鸟嘌呤核苷酸交换因子活性驱动肾脏囊肿形成

Ciliary ARL13B Drives Cystogenesis in the Kidney by Its Guanine Nucleotide Exchange Factor Activity.
PubMed 文献 · J Am Soc Nephrol · 2026-08-24

该研究利用两种Arl13b小鼠等位基因(Arl13bV358A和Arl13bR79Q)在Pkd1缺陷成年小鼠模型中探究ARL13B是否为纤毛依赖性囊肿激活(CDCA)通路的组分。结果显示,丢失纤毛ARL13B或突变其ARL3 GEF活性关键残基可抑制Pkd1依赖性囊肿,并减少肾脏大小、囊肿指数、BUN、纤维化、损伤及β-catenin和cyclin D1蛋白水平。结论表明,纤毛中ARL13B的GEF活性是驱动肾脏囊肿形成的关键机制。

要点

  • 丢失纤毛ARL13B可抑制成年Pkd1缺陷小鼠的囊肿形成而不消除纤毛。
  • ARL13B的ARL3 GEF活性关键残基突变可抑制Pkd1依赖性囊肿。
  • 抑制囊肿伴随肾脏大小、囊肿指数、BUN、纤维化及损伤减轻。

核心结论

  • 纤毛ARL13B通过其鸟嘌呤核苷酸交换因子活性驱动Pkd1依赖性肾脏囊肿形成。

研究设计与样本

  • 使用两种Arl13b小鼠等位基因(Arl13bV358A和Arl13bR79Q)在Pkd1缺陷成年小鼠模型中研究。

主要发现

  • 丢失纤毛ARL13B或突变其ARL3 GEF活性关键残基抑制了Pkd1依赖性囊肿。
  • 观察到肾脏大小、囊肿指数和BUN降低。
  • 肾脏纤维化、肾脏损伤以及β-catenin和cyclin D1蛋白水平受到抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Loss of ciliary ARL13B suppressed cystogenesis in the kidneys of an adult mouse model of polycystic kidney disease without ablating cilia. Loss of ciliary ARL13B or the residue critical for its guanine nucleotide exchange factor activity did not affect kidney morphology or physiology in an adult induced mouse model. Mutation of a residue critical for ARL13B activation of ARL3 suppressed cystic phenotypes in Pkd1 -dependent cysts. BACKGROUND: Polycystic kidney disease (PKD) is the leading genetic cause of kidney failure, resulting in the accumulation of fluid-filled cysts and gross enlargement of the kidney. Mutations in PKD1 or PKD2 , which encode ciliary polycystin proteins, are the most common cause of PKD. These proteins function in a cilia-dependent cyst activation (CDCA) pathway-one that requires cilia for its procystic function-yet the molecular driver(s) of this pathway are unknown. ARL13B is a regulatory GTPase enriched in cilia and links to cystogenesis in the kidneys. ARL13B possesses guanine nucleotide exchange factor (GEF) activity for ARL3, another ADP-ribosylation factor-like family GTPase with links to cilia. METHODS: We used 2 distinct Arl13b mouse alleles to investigate whether ARL13B is a component of the CDCA pathway: Arl13bV358A encodes for enzymatically normal ARL13B that is undetectable in cilia, and Arl13bR79Q encodes for cilia-localized ARL13B lacking a residue critical for its ARL3 GEF activity. We used these alleles in a Pkd1 -deficient adult mouse model and investigated kidney morphology (hematoxylin and eosin and cystic index analysis), physiology (BUN measurements), kidney fibrosis (picrosirius staining and α -smooth muscle actin levels), kidney injury (SRY box transcription factor 9 immuno-fluorescent staining and quantification), and Wnt signaling ( β -catenin and cyclin D1 protein levels). RESULTS: We found that loss of ciliary ARL13B or mutation of a single residue critical for its ARL3 GEF activity suppressed Pkd1 -dependent cysts. We observed reductions in kidney size, cystic index, and BUN. We also observed suppression of kidney fibrosis, kidney injury, and β -catenin and cyclin D1 protein levels. CONCLUSIONS: Our results identified a subcellular location and mechanism driving Pkd1 -dependent cystogenesis in the kidneys. We demonstrated that expression of a critical residue for ARL13B's GEF activity specifically in cilia is a key mechanism of the CDCA pathway driving cystogenesis in the kidneys.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Van Sciver RE, Forster A, Lewis LM, et al. Ciliary ARL13B Drives Cystogenesis in the Kidney by Its Guanine Nucleotide Exchange Factor Activity. J Am Soc Nephrol. 2026. PMID: 42636066. doi:10.1681/ASN.0000001238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。